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Yes
• Potency 
• Confidence
• Cost (time, products, etc.)
Do Storage and Handling Matter?
Storage and Handling Recommendations
Primary source for CDC storage 
and handling 
recommendations
• Most current 
recommendations
• Other materials updated 
based on toolkit contents
Vaccine Storage and Handling Toolkit
www.cdc.gov/vaccines/hcp/admin/storage/toolkit/storage-handling-toolkit.pdf
Vaccine Cold Chain

Well-trained staff
Reliable storage and 
temperature 
monitoring equipment
Accurate vaccine 
inventory management
Three Keys to Cold Chain Management
www2.cdc.gov/vaccines/ed/shvideo/
Staff and Training
SOPs
• Routine
• Emergency
Complete training:
• As part of employee 
orientation
• Annually
• When new vaccines are added
• When recommendations 
change
Staff Training
www.cdc.gov/vaccines/hcp/admin/storage/toolkit/storage-handling-toolkit.pdf
www.cdc.gov/vaccines/ed/youcalltheshots.html
Primary coordinator
• Responsible for ensuring all vaccines 
are stored and handled properly
• Expert on routine and emergency SOPs
• Review and update SOPs annually
Alternate coordinator
• Expert that can assist primary and 
fulfill duties in their absence
All other staff
• May delegate duties to trained staff
Primary and Alternate Coordinator Duties
Equipment
Purpose-built or 
pharmaceutical-grade 
(large or compact)
Household-grade
• Do not use freezer
Equipment: Vaccine Storage Units
Equipment: Vaccine Storage Units
Compact, purpose-built unit:            Dormitory-style unit:
Yes No
Equipment: Vaccine Storage Units
Recommended features
• Detachable buffered 
probe
• Alarm
• Low battery indicator
• Min/max display
• Uncertainty of +/-0.5°
C (+/-1° F) 
• 30-minute reading rate
Equipment: Temperature Monitoring Devices (TMDs)
Alcohol or mercury 
thermometers
Bimetal stem TMDs 
TMDs used for food 
Chart recorders 
 Infrared TMDs 
TMDs without Certificate of 
Calibration Testing
TMDs Not Recommended for Use
Should include:
• Model/device name or 
number 
• Serial number 
• Date of calibration 
• Confirmation that the 
instrument passed testing
• Recommended uncertainty 
of +/-0.5° C (+/-1° F) or less 
Certificate of Calibration
Device displays min/max, 
preferably a DDL with 
buffered probe:
• Check and record min/max 
temperature at the start of 
each workday
Device does not display 
min/max:
• Check and record current 
temperature 2 times, at the 
start and end of the 
workday
Monitoring Storage Unit Temperatures
IAC Temperature monitoring logs: www.immunize.org/handouts/temperature-logs.asp
Temperature Excursion
www.cdc.gov/vaccines/hcp/admin/storage/toolkit/storage-handling-toolkit.pdf
www.cdc.gov/vaccines/hcp/admin/storage/downloads/temperature-excursion-508.pdf
www.immunize.org/handouts/temperature-logs.asp
www.immunize.org/catg.d/p3041.pdf
Danger zones
 Labels
 Look-alike/sound-alike
Air circulation
Expiring products
Water bottle placement
Organization
Vaccine Inventory Management
Maintain cold chain; immediately check and store vaccines 
upon arrival
• Unpack
• Examine and document
oDamage
oReceipt of order
oExpiration dates
oDiluents
oCold chain monitor
• Immediately store at recommended temperature
• Notify manufacturer or others as appropriate if any issues
Vaccine Delivery
Stock record
• Delivery date
• Name or initials of person who unpacked delivery
• Manufacturer
• Lot number and expiration date
• Number of doses
• Delivery cold chain monitor reading 
• Number of doses used and balance
Vaccine Inventory and Stock Records
Rotate stock so that vaccines that expire first are used first
• Rotate stock weekly and when there are deliveries
• Remove expired stock and handle per policy (return, discard, 
etc.)
Avoid overstocking of vaccine supply
• Check stock and anticipate upcoming patient needs (i.e., flu 
season, back to school, community event, etc.)
• Reorder at approximately 4 weeks worth of inventory
Other Inventory Issues
Expired or compromised vaccine
Open or broken vials and manufacturer prefilled syringes
Empty vaccine vials
Medical waste disposal
Vaccine Disposal
Vaccine Transport
Off-site or satellite facilities
Shipping
Emergency
Transport Situations
www.cdc.gov/vaccines/recs/storage/downloads/emergency-transport.pdf
Transport Systems
Protocols
• Identify trained staff
• Vehicles
• Inventory 
• Documentation
• Contact emergency vaccine 
storage facility
• Suspend operations prior 
to emergency
Vehicle considerations
• Company or personal vehicle
• Use passenger compartment
• Avoid sunlight
• Monitor vaccine temperature
• Move vaccines into storage 
unit upon arrival
Transport Planning
 For any type of transport:
• Use a temperature monitoring device (DDL preferred)
• Place buffered probe with vaccines
• Keep display on top
Temperature Monitoring during Transport
Emergency Vaccine Storage and Handling
Alternative storage facility
• Even if generator is on-site
Additional storage unit(s)
• In use or for emergency use
Backup generator
• May prevent need for transport
Backup battery power source
Emergency Backup Equipment
Keep storage units and containers closed
Use TMDs
Use one of the following containers:
• Qualified containers and packouts
• Portable vaccine unit (if power source available)
• Packing Vaccines for Transport during Emergencies system
Alternative Facility Inaccessible
Record room temperature
Record min/max storage unit temperatures
• As soon as the power goes out AND during the outage
Avoid temperature excursions
• Shift to transport plan or use alternative containers 
 If temp reading can only be obtained by opening door and 
there is no alternative facility, wait until power is restored
• Record room and unit temperatures (min/max, if available)
• Length of time power was off
• Follow procedures for temperature excursion, if one occurred
Power Outage
Vaccine Preparation
Use designated clean preparation area
Prepare vaccine only when ready to 
administer
Use diluent supplied by manufacturer
Verify, verify, then verify again
Prepare your own vaccines
Vaccine Preparation Best Practices
Generally not recommended, but if you must…
• Prepare at site or event in clean area
• Separate administration stations if multiple vaccines
• One MDV or 10 doses per provider
• Monitor patient flow
• Additional guidance for reconstituted vaccines
Best practice: Use manufacturer prefilled syringes for large 
vaccination clinics
Predrawing Vaccines
Vaccine 
Administration2
Key to ensuring vaccination is as safe and effective as possible 
 Incorporate: 
• Professional standards for 
medication administration 
• Manufacturers’ vaccine-specific 
guidelines 
• Evidence-based safe injection 
practices on CDC’s Injection Safety 
Information for Providers web page
www.cdc.gov/injectionsafety/providers.html
Vaccine Administration 
http://www.cdc.gov/injectionsafety/ 
Before administering vaccines, all personnel who
administer vaccines should:
• Receive competency-based training
• Have knowledge and skills validated
 Integrate competency-based training into:
• New staff orientation
• Annual education requirements
Ongoing education:
• When vaccine administration recommendations
are updated
• When new vaccines are added to the inventory
Staff Training and Education 
Skills Checklist for Immunization: www.immunize.org/catg.d/p7010.pdf
 Screening checklist 
 Review the immunization history: 
• Accept only written, dated records (except 
influenza and PPSV23 self-report) 
• Use recommended schedule
 Screen for contraindications and 
precautions 
 Discuss vaccine benefits and risks and 
vaccine-preventable disease risks using 
VISs and other reliable resources 
 Provide after-care instructions
Before Administering Vaccines 
www.immunize.org/catg.d/p4060.pdf
www.immunize.org/catg.d/p4065.pdf
www.cdc.gov/vaccines/parents/tools/tips-factsheet.pdf
immunize.org/handouts/discussing-vaccines-parents.asp
Encourage parent/guardian to hold child 
Sitting rather than lying down (young child) 
Be aware of syncope (fainting):
• Have patient seated or lying down during vaccination 
• Be aware of symptoms that precede syncope 
• If patient faints, provide supportive care and protect patient 
from injury 
• Observe patient (seated or lying down) for at least 15 minutes 
after vaccination
Positioning and Comforting Restraint
Pharmacological 
• Topical anesthetics
• Sweet-tasting solutions 
Physical
• Breastfeeding 
• Positioning – parent holding the infant or young child  
• Sitting upright rather than lying down
• Tactile stimulation
Procedural Pain Management Strategies 
Taddio, Anna, et al. Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline. CMAJ 2010;182:500–515
Psychological 
• Distraction (i.e., games on smart phones)
• Deep breathing (i.e., young children can blow bubbles)
Procedural
• Order of injection: Administer the vaccine most painful when 
injected last 
• Rapid injection without aspiration
Process intervention
• Educating and training staff; implementing a planned 
approach to address procedural pain management  
Procedural Pain Management Strategies
Taddio, Anna, et al. Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline. CMAJ 2010;182:500–515
Procedural Pain Job Aids  
www.cmaj.ca/content/suppl/2015/08/24/cmaj.150391.DC1
 Perform hand hygiene:
• Before preparing vaccines
• Between patients
• Anytime hands become soiled
 Gloves are not required when administering vaccines unless the person 
administering the vaccine is likely to come into contact with potentially 
infectious body fluids or has open lesions on hands:
• If gloves are worn, they should be changed between patients
• Perform hand hygiene between patients even if wearing gloves
 Equipment disposal:
• Puncture-proof biohazard container
• Empty or expired vaccine vials are medical waste
Infection Control
www.cdc.gov/handhygiene/index.html
Never combine vaccines into a single syringe
Never transfer vaccine from one syringe to another
Never draw partial doses of vaccine from separate vials to 
obtain a full dose 
Vaccine Preparation “Nevers” 
Oral (PO):
• Administer liquid inside cheek slowly 
down one side (between cheek and gum) 
toward the back of infant’s mouth 
 Intranasal (NAS): 
• LAIV4 is the only vaccine administered by 
the intranasal route 
Route and Site 
www.cdc.gov/vaccines/hcp/admin/resource-library.html
www.cdc.gov/mmwr/preview/mmwrhtml/mm6304a4.htm?s_cid=mm6304a4_w
Dermis
Fatty tissue (SubQ)Muscle tissue
45° Angle
Subcutaneous Injection Route
Site: 
• Thigh for infants < 12 months of age 
• Upper outer triceps of arm for children > 12 
months and adults (can be used for infants if 
necessary) 
Needle gauge and length: 
• 23–25 gauge needle, 5/8 inch
Technique:
• To avoid reaching the muscle, pinch up the 
fatty tissue, insert the needle at a 45° angle, 
and inject the vaccine into the tissue
Dermis
Muscle tissue
Fatty tissue 
90° Angle
Aspiration is NOT required
Spread the skin of the site taut 
between the thumb and forefinger, 
isolating the muscle 
Another technique, acceptable 
mostly for pediatric and geriatric 
patients, is to grasp the tissue and 
“bunch up” the muscle 
 Insert the needle fully into the 
muscle at a 90° angle and inject 
Intramuscular Injection (IM) Route
Site: 
• Vastus lateralis muscle                                                               
(anterolateral thigh) 
Needle gauge and length:
• 22–25 gauge 
• Neonates and preterm infants: 5/8 inch 
(adequate only if the skin is stretched flat 
between thumb and forefinger) 
• 1 month and older: 1 inch 
Intramuscular Injection (IM) Route: Infants <12 Months
Site: 
• Vastus lateralis muscle (anterolateral 
thigh) is preferred 
• Deltoid muscle (upper arm) may be used 
if the muscle mass is adequate 
Needle gauge and length: 
• 22–25 gauge 
• 5/8 to 1 inch (5/8 inch adequate only for 
the deltoid muscle and only if the skin is 
stretched flat between thumb and 
forefinger) 
Intramuscular Injection (IM) Route: 1–2 Years 
 Site: 
• Deltoid muscle (upper arm) is preferred 
• Vastus lateralis muscle (anterolateral thigh) may be used 
 Needle gauge and length: 
• 22–25 gauge 
• 5/8 to 1 inch 
 Most young children in this age range require a 5/8 or 
1 inch needle: 
• 5/8 inch needle is adequate only for the deltoid muscle and 
only if the skin is stretched flat between thumb and forefinger 
 Older children and adolescents require a 1 inch 
needle 
Intramuscular Injection (IM) Route: 3–18 Years 
Site:
• Deltoid muscle (upper arm) is preferred
• Vastus lateralis muscle (anterolateral 
thigh) may be used
Needle gauge: 23–25 gauge
Needle length varies with patient size
Intramuscular (IM) Route
Adults 19 Years and Older
 Shoulder injury related to vaccine administration (SIRVA) was 
added to the Vaccine Injury Compensation Table in March 2017
 Shoulder injuries related to vaccine administration are injuries to 
the musculoskeletal structure of the shoulder, including the 
ligaments, bursa, and tendons
• They are thought to occur as a result of the unintended injection 
of vaccine antigen and/or trauma from the needle going into and 
around the underlying bursa of the shoulder 
• Symptoms include shoulder pain and limited mobility after the 
injection
Shoulder Injury Related to Vaccine Administration 
When administering a vaccine by intramuscular (IM) injection 
in the deltoid muscle, use: 
• Proper landmarks and technique to identify the injection site
• Proper needle length based on the age, patient size, and 
injection technique
Shoulder Injury Related to Vaccine Administration 
and Vaccine Administration Best Practices 
CDC vaccine administration 
web page for information and 
materials for health care 
personnel, including:
• IM demonstration video
• Job aids and infographics 
Clinical Resources for Shoulder Injury Related to Vaccine 
Administration  
Vaccine Administration: www.cdc.gov/vaccines/hcp/admin/administer-vaccines.html
Separate injections by at least 1 inch (or more if possible)
Use a separate limb for most reactive vaccines, if possible
Use combination vaccines when appropriate to reduce the
number of injections
Multiple Vaccinations 
http://www.aimtoolkit.org/health-care/vaccine-administration.php 
 Federally required documentation:
• Date of administration
• Vaccine manufacturer
• Vaccine lot number
• Name and title of person who administered 
vaccine and address of clinic or facility where 
permanent record will reside
• Vaccine information statement (VIS)
o Date printed on the VIS
o Date VIS given to patient or parent/guardian
 Best practice documentation:
• Vaccine type (ACIP abbreviation)
• Route
• Dosage (volume)
• Site
Documentation
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 Establish an environment that values reporting and 
investigating errors as part of risk management and quality 
improvement
Use best practices for storing, handling, preparing, and 
administering vaccines
 Take immediate action and isolate affected vaccine(s) if there is 
a temperature excursion
Promptly remove expired vaccines from the storage unit
Strategies to Prevent Errors
Only administer vaccines you have prepared and triple-
checked
Be familiar with current recommended immunization 
schedules: 
www.cdc.gov/vaccines/acip/index.html
Use standing orders when possible: 
www.immunize.org/standing-orders/
Strategies to Prevent Errors
 Inform the patient/parent of the error
Determine the status of the patient
Explain any needed next steps
Know how to correct the error
• Contact your local health department, vaccine manufacturer, 
or nipinfo@cdc.gov for guidance
Record the vaccine as it was given on the medical 
administration record
What if a Vaccination Error Occurs?
Providers are encouraged to 
report vaccination errors 
without health events if they 
believe the error may pose a 
safety risk
VAERS encourages reports of 
clinically significant adverse 
health events
Reporting Vaccination Errors to VAERS
vaers.hhs.gov/reportevent.html
